National Government Services Expands Coverage for Bio-Techne’s ExoDx Prostate Cancer Test

Medicare administrative contractor National Government Services has released an updated local coverage determination expanding coverage of Bio-Techne’s ExoDx Prostate Test.

Under the updated LCD, which goes into effect March 1, the contractor will cover the EPI test once per year in patients with at least one prior negative biopsy who need a repeat biopsy and are thought to be at higher risk.